JP2003509369A5 - - Google Patents

Download PDF

Info

Publication number
JP2003509369A5
JP2003509369A5 JP2001523001A JP2001523001A JP2003509369A5 JP 2003509369 A5 JP2003509369 A5 JP 2003509369A5 JP 2001523001 A JP2001523001 A JP 2001523001A JP 2001523001 A JP2001523001 A JP 2001523001A JP 2003509369 A5 JP2003509369 A5 JP 2003509369A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
group
choh
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001523001A
Other languages
English (en)
Japanese (ja)
Other versions
JP5116928B2 (ja
JP2003509369A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/024892 external-priority patent/WO2001019367A1/en
Publication of JP2003509369A publication Critical patent/JP2003509369A/ja
Publication of JP2003509369A5 publication Critical patent/JP2003509369A5/ja
Application granted granted Critical
Publication of JP5116928B2 publication Critical patent/JP5116928B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001523001A 1999-09-13 2000-09-12 ケトチフェン及びその治療上有効な代謝産物の光学活性異性体 Expired - Fee Related JP5116928B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US15356699P 1999-09-13 1999-09-13
US60/153,566 1999-09-13
US19798500P 2000-04-15 2000-04-15
US19790600P 2000-04-15 2000-04-15
US19736300P 2000-04-15 2000-04-15
US19790500P 2000-04-15 2000-04-15
US60/197,985 2000-04-15
US60/197,905 2000-04-15
US60/197,363 2000-04-15
US60/197,906 2000-04-15
PCT/US2000/024892 WO2001019367A1 (en) 1999-09-13 2000-09-12 Optically active isomers of ketotifen and therapeutically active metabolites thereof

Publications (3)

Publication Number Publication Date
JP2003509369A JP2003509369A (ja) 2003-03-11
JP2003509369A5 true JP2003509369A5 (cg-RX-API-DMAC7.html) 2007-09-27
JP5116928B2 JP5116928B2 (ja) 2013-01-09

Family

ID=27538454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001523001A Expired - Fee Related JP5116928B2 (ja) 1999-09-13 2000-09-12 ケトチフェン及びその治療上有効な代謝産物の光学活性異性体

Country Status (18)

Country Link
US (3) US7226934B1 (cg-RX-API-DMAC7.html)
EP (1) EP1218007B1 (cg-RX-API-DMAC7.html)
JP (1) JP5116928B2 (cg-RX-API-DMAC7.html)
CN (1) CN1391475A (cg-RX-API-DMAC7.html)
AR (1) AR034396A1 (cg-RX-API-DMAC7.html)
AT (1) ATE516804T1 (cg-RX-API-DMAC7.html)
AU (1) AU782816B2 (cg-RX-API-DMAC7.html)
BR (1) BR0013935A (cg-RX-API-DMAC7.html)
CA (1) CA2383222C (cg-RX-API-DMAC7.html)
CY (1) CY1112605T1 (cg-RX-API-DMAC7.html)
DK (1) DK1218007T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0202671A3 (cg-RX-API-DMAC7.html)
IL (2) IL148368A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02002658A (cg-RX-API-DMAC7.html)
MY (1) MY134888A (cg-RX-API-DMAC7.html)
PL (1) PL353586A1 (cg-RX-API-DMAC7.html)
PT (1) PT1218007E (cg-RX-API-DMAC7.html)
WO (1) WO2001019367A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL353586A1 (en) * 1999-09-13 2003-12-01 Bridge Pharma, Inc.Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
AU2009257259B2 (en) 2008-06-13 2013-05-02 Case Western Reserve University Compostions and methods for treating corneal inflammation
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
JP2012520880A (ja) * 2009-03-17 2012-09-10 アーシエックス セラピューティックス, インコーポレイテッド ケトチフェンの眼科用製剤および使用方法
US9296731B2 (en) 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US20150272941A1 (en) * 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US20140120121A1 (en) * 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US9138431B2 (en) * 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
US9345697B2 (en) * 2013-08-06 2016-05-24 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus
US9439895B2 (en) * 2013-08-06 2016-09-13 Bridge Pharma, Inc. Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
CN104059056B (zh) * 2014-06-26 2017-08-25 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬晶型b及其制备方法
EP3307270B1 (en) * 2015-06-11 2018-10-17 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus in mammals
US9694003B2 (en) 2015-10-15 2017-07-04 Bridge Pharma, Inc. Formulations and methods for treating high intraocular pressure
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途
MY204310A (en) 2016-09-08 2024-08-22 Emergo Therapeutics Inc Mast cell stabilizers for treatment of hypercytokinemia and viral infection
US11478463B2 (en) 2016-10-18 2022-10-25 Emergo Therapeutics, Inc. Mast cell stabilizers for treatment of chronic inflammatory conditions
US20200268734A1 (en) * 2019-02-22 2020-08-27 Bridge Pharma, Inc. Methods of treatment of respiratory disorders
US10959992B2 (en) 2019-02-22 2021-03-30 Bridge Pharma Inc. Methods of treatment of asthma and COPD

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1089483A (en) 1964-02-04 1967-11-01 Sandoz Ltd Improvements in or relating to 4h-benzo(4,5)cyclohepta (1,2-b) thiophene derivatives
FR1447527A (fr) 1964-08-11 1966-07-29 Sandoz Sa Nouveaux benzo-cyclohepta-thiophènes et leur préparation
CH531000A (de) 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
BE794377A (fr) * 1972-01-24 1973-07-23 Sandoz Sa Nouveaux derives du benzo-cyclohepta-thiophene
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
US4073915A (en) 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
US4128549A (en) 1976-02-27 1978-12-05 Sandoz Ltd. Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones
CS263993B1 (cs) 1988-03-11 1989-05-12 Polivka Zdenek Způsob přípravy čistých enantiomerů 4- (l-meíhyl-4-piperidyliden) -4,9-dihydrobenzo [ 4,5) cyklohepta [ 1,2-b ] - thiofen-lQ-onu
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
GB9012926D0 (en) * 1990-06-09 1990-08-01 Scras Pyrrolo-pyridine derivatives
US5416087A (en) * 1990-10-10 1995-05-16 Wong; Jesse K. Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
JP3026841B2 (ja) * 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
CA2123909C (en) * 1991-12-18 2002-10-01 Christer Carl Gustav Carling New combination of formoterol and budesonide
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
PL336007A1 (en) 1997-04-03 2000-06-05 Bridge Pharma Chemical compounds of benzocycloheptathiophene
US6207684B1 (en) * 1997-06-09 2001-03-27 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
PL353586A1 (en) * 1999-09-13 2003-12-01 Bridge Pharma, Inc.Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof

Similar Documents

Publication Publication Date Title
TWI658836B (zh) 治療肺部疾病的高穿透力前藥組合物、其醫藥組合物及其用途
JP5116928B2 (ja) ケトチフェン及びその治療上有効な代謝産物の光学活性異性体
JP2011504490A5 (cg-RX-API-DMAC7.html)
JP3861250B2 (ja) 5−ht2拮抗剤による強迫性障害処置剤
MXPA03011448A (es) Derivados de n-arilfenilacetamida y composicion farmaceutica que los contienen.
JP2003512429A (ja) デスロラタジンを用いた睡眠障害処置
US20200147228A1 (en) Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia
JP2002521468A5 (cg-RX-API-DMAC7.html)
HUP0102706A2 (hu) Hatóanyagok salétromsavval alkotott észterei és nitrátsói
EP1123702A1 (en) Analgesics
JP2020073513A (ja) α,ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法
JP2003513075A5 (cg-RX-API-DMAC7.html)
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors
ES2296964T3 (es) Compuestos a base de nitrato organico para el tratamiento de ateroesclerosis y enfermedades vasculares.
JP2004514709A5 (cg-RX-API-DMAC7.html)
KR101160858B1 (ko) 소양 치료약으로서 유용한 4-(2-푸로일)아미노피페리딘류
JP2004509871A5 (cg-RX-API-DMAC7.html)
US6197796B1 (en) Anticancer composition comprising a diaminotrifluoromethylpyridine derivative
RU2002109706A (ru) Оптически активные изомеры кетотифена и их терапевтически активные метаболиты
CA2290557C (en) Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
WO2004032964A1 (ja) アレルギー性疾患治療剤
JP2004512376A5 (cg-RX-API-DMAC7.html)
JP2002541190A (ja) 気分障害治療用医薬を製造するためのオサネタントの使用
WO2010038240A9 (en) Pharmaceutical composition comprising nimesulide and levocetirizine
JP2004509870A5 (cg-RX-API-DMAC7.html)